194 related articles for article (PubMed ID: 22591387)
1. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
Robak T; Robak P
Curr Pharm Des; 2012; 18(23):3373-88. PubMed ID: 22591387
[TBL] [Abstract][Full Text] [Related]
2. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Robak T; Lech-Maranda E; Korycka A; Robak E
Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
[TBL] [Abstract][Full Text] [Related]
3. Older and new purine nucleoside analogs for patients with acute leukemias.
Robak P; Robak T
Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
[TBL] [Abstract][Full Text] [Related]
4. Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Robak T; Korycka A; Kasznicki M; Wrzesien-Kus A; Smolewski P
Curr Cancer Drug Targets; 2005 Sep; 5(6):421-44. PubMed ID: 16178817
[TBL] [Abstract][Full Text] [Related]
5. Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
Robak T; Korycka A; Lech-Maranda E; Robak P
Molecules; 2009 Mar; 14(3):1183-226. PubMed ID: 19325518
[TBL] [Abstract][Full Text] [Related]
6. Novel purine nucleoside analogues for hematological malignancies.
Korycka A; Lech-Marańda E; Robak T
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
[TBL] [Abstract][Full Text] [Related]
7. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
Robak T
Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2006 May; 6(5):575-81. PubMed ID: 16719832
[TBL] [Abstract][Full Text] [Related]
9. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
[TBL] [Abstract][Full Text] [Related]
10. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Cheson BD; Vena DA; Barrett J; Freidlin B
J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
[TBL] [Abstract][Full Text] [Related]
11. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
Pott-Hoeck C; Hiddemann W
Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
[TBL] [Abstract][Full Text] [Related]
12. Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application.
Korycka A; Błoński JZ; Robak T
Mini Rev Med Chem; 2007 Sep; 7(9):976-83. PubMed ID: 17897085
[TBL] [Abstract][Full Text] [Related]
13. Pentostatin and purine analogs for indolent lymphoid malignancies.
Ho AD; Hensel M
Future Oncol; 2006 Apr; 2(2):169-83. PubMed ID: 16563086
[TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside analogues in the treatment of myleoid leukemias.
Robak T
Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
[TBL] [Abstract][Full Text] [Related]
15. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Larson RA
Semin Oncol; 2007 Dec; 34(6 Suppl 5):S13-20. PubMed ID: 18086342
[TBL] [Abstract][Full Text] [Related]
16. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
Polliack A
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():41-51. PubMed ID: 9570679
[TBL] [Abstract][Full Text] [Related]
17. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
[TBL] [Abstract][Full Text] [Related]
18. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E; Cardoen S; Offner F; Bontemps F
Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
[TBL] [Abstract][Full Text] [Related]
19. Novel drugs for chronic lymphoid leukemias: mechanism of action and therapeutic activity.
Robak T
Curr Med Chem; 2009; 16(18):2212-34. PubMed ID: 19519388
[TBL] [Abstract][Full Text] [Related]
20. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
